Aug. 5 at 2:48 AM
$GRCE GRCE Grace Therapeutics Announces
$10 Million Private Placement
"today announced that it has entered into a securities purchase agreement for a private placement financing with new and existing fundamental investors. The financing is expected to result in aggregate gross proceeds to the Company of approximately
$10 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds from the financing to support the manufacturing and regulatory work needed to advance GTx-104.
Grace Therapeutics will issue an aggregate of 4,761,904 shares of common stock at a price of at
$2.10 per share."
